NCT05850637View on ClinicalTrials.gov

Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

February 11, 2021

Study Completion Date

April 1, 2023

Conditions
Breast Cancer Female
Interventions
RADIATION

adjuvant ultra-hypofractionated radiotherapy

adjuvant ultra-hypofractionated radiotherapy for the treatment of early and locally advanced breast cancer

Trial Locations (1)

Unknown

Instituto de Pesquisa Prevent Senior, São Paulo

All Listed Sponsors
lead

Prevent Senior Institute

OTHER

NCT05850637 - Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer | Biotech Hunter | Biotech Hunter